Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

640 public trials 137 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Completed

Liquid Biopsy: Intercepting Mutational Trajectories of HER2 (Human Epidermal Growth Factor Receptor 2) Breast Cancer (GIM21 Trial)

NCT05735392

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • A.O. Ospedale Papa Giovanni XXIII - Oncologia Bergamo, Italy
  • I.R.C.C.S. A.O.U San Martino - IST Genova, Italy
  • A.O.U. Policlinico di Modena Modena, Italy
  • Azienda Ospedaliera Universitaria Federico II Naples, Italy
View Trial Details
Completed

Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer

NCT00608972

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Cooper Hospital/University Medical Center Camden, New Jersey, United States
  • Cancer Institute of New Jersey at Hamilton Hamilton, New Jersey, United States
  • Morristown Medical Center Morristown, New Jersey, United States
  • Jersey Shore University Medical Center Neptune City, New Jersey, United States
View Trial Details
Completed

Real-World Data on Clinical Characteristics, Demographics, and Outcomes of Patients With Metastatic Breast Cancer in Turkey

NCT04770129

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Ege University Hospital Izmir, Bornova, Turkey (Türkiye)
  • Istanbul University Istanbul, Fatih, Turkey (Türkiye)
  • Acibadem Maslak Hospital Istanbul, Maslak, Turkey (Türkiye)
  • Marmara University Pendik Training and Research Hospital Istanbul, Pendik, Turkey (Türkiye)
View Trial Details
Completed

G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer

NCT03455270

Conditions
Adenocarcinoma, Advanced Breast Cancer, Breast Cancer, +16 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Stanford Women Cancer Center Stanford, California, United States
  • Northwestern University - Feinberg School of Medicine Chicago, Illinois, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View all 15 locations
View Trial Details
Completed

Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer

NCT02657889

Conditions
Adnexal Diseases, Advanced Breast Cancer, Breast Cancer, +27 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 30 locations
View Trial Details

Related conditions